GO:0070571 negative regulation of neuron projection regeneration: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070571 describes any process that stops, prevents, or reduces the frequency, rate or extent of neuron projection regeneration, the regrowth of axons or dendrites after loss or damage.
• It is a biological_process term whose classical synonym is growth cone collapse, reflecting the cytoskeletal disassembly that halts neurite extension.
• Key inhibitory molecules include RhoA/Rac1 GTPases, Celsr2, SCG10/stathmin, SPRR1A and cell adhesion molecules that transduce repulsive cues.
• Negative regulation is essential for correct wiring during development and for preventing aberrant sprouting after stroke, traumatic brain injury and spinal cord injury.
• Dysregulated inhibition contributes to failed regeneration in the injured CNS and to altered nerve repair in the periphery.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate inhibitory genes in neurons and animal models.
Description
GO:0070571, negative regulation of neuron projection regeneration, is a Gene Ontology biological_process term that captures the cellular programs which actively stop, prevent, or reduce the regrowth of neuronal processes such as axons or dendrites following their loss or damage. Rather than being a passive failure of growth, this term describes an active inhibitory process that includes growth cone collapse and the signaling events that terminate neurite extension. Understanding this process is central to neurobiology because the balance between growth-promoting and growth-inhibitory cues determines whether injured neurons can reconnect. The term is experimentally tractable: dominant-negative GTPase expression, genetic inactivation of guidance receptors, and microRNA-mediated suppression of regeneration-associated proteins have all been used to manipulate it in vivo. Researchers study GO:0070571 to identify molecular brakes on regeneration and to ask whether relieving those brakes can restore function after nerve injury, stroke, or spinal cord trauma.
negative regulation of neuron projection regeneration At A Glance
| GO ID | GO:0070571 |
|---|---|
| GO term | negative regulation of neuron projection regeneration |
| Ontology | biological_process |
| Synonym | growth cone collapse |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of neuron projection regeneration, the regrowth of axons or dendrites after loss or damage |
| Biological context | Axon and dendrite regrowth after injury; developmental wiring; growth cone collapse |
| Representative regulators | RhoA, Rac1, Celsr2, SCG10/stathmin, SPRR1A, cell adhesion molecules |
| Disease relevance | Failed CNS regeneration after stroke, traumatic brain injury and spinal cord injury; peripheral nerve regeneration defects |
| Experimental readouts | Neurite outgrowth assays, growth cone collapse assays, nerve regeneration indices, axon fasciculation measurements |
What Is GO:0070571?
In our own words, GO:0070571 refers to any biological process that stops, prevents, or reduces the frequency, rate, or extent of neuron projection regeneration, meaning the regrowth of neuronal processes such as axons or dendrites after they are lost or damaged. The term is a negative regulatory biological_process and is classically associated with growth cone collapse, the retraction of the motile tip of a growing neurite. It encompasses signaling events, cytoskeletal rearrangements, and extracellular cues that actively oppose regrowth rather than merely failing to support it.
Why Is negative regulation of neuron projection regeneration Important in Cell Biology?
GO:0070571 matters because the capacity of neurons to regrow projections after injury is limited by active inhibitory programs, and manipulating these programs is a leading strategy for promoting repair. Gene expression changes after focal stroke, traumatic brain injury and spinal cord injury reshape the balance of growth-promoting and growth-inhibitory cues, making this term a hub for understanding regeneration failure. Because the process is genetically encoded, it can be dissected with precision using dominant-negative constructs, genetic inactivation, and CRISPR-based models, which links basic mechanism to translational neuroregeneration.
• Defines an active cellular brake on axon and dendrite regrowth after injury.
• Explains growth cone collapse, a classic readout of regeneration inhibition.
• Connects Rho-family GTPase signaling to neurite outgrowth arrest.
• Links atypical cadherin signaling, such as Celsr2, to motor axon fasciculation and regeneration.
• Involves microtubule destabilizing proteins SCG10 and stathmin in growth control.
• Includes post-transcriptional suppression of regeneration-associated proteins such as SPRR1A by microRNAs.
• Relevant to cell adhesion molecule-mediated regulation of neurite outgrowth.
• Provides a framework for interpreting gene expression changes after stroke, traumatic brain injury and spinal cord injury.
• Supports development of neuroregenerative strategies that relieve inhibitory cues.
• Enables mechanistic studies using magnetic or mechanical modulation of neurite outgrowth in human cells.
What Happens During negative regulation of neuron projection regeneration?
Initiation by inhibitory cues and receptor activation
In simple terms: A 'stop growing' signal is received at the tip of the neuron.
Negative regulation of neuron projection regeneration begins when extracellular inhibitory cues or guidance molecules engage neuronal receptors and initiate intracellular signaling that opposes regrowth. Cell adhesion molecules and their downstream pathways are key regulators of neurite outgrowth and can convert environmental cues into growth-inhibitory signals. In this phase, the growth cone, the motile tip of the extending neurite, becomes the site where repulsive information is integrated.
Rho-family GTPase signaling and cytoskeletal collapse
In simple terms: The internal skeleton of the growth tip is dismantled so it can no longer push forward.
A central step is activation of Rho-family GTPases such as RhoA and Rac1, which reorganize the actin cytoskeleton and drive growth cone collapse. Adenovirus-mediated expression of dominant negative RhoA and Rac1 enhances sciatic nerve regeneration, demonstrating that these GTPases restrain projection regrowth in vivo. This cytoskeletal rearrangement is the physical basis of the growth cone collapse synonym for GO:0070571.
Microtubule destabilization by SCG10 and stathmin
In simple terms: Proteins that normally keep the neuron's internal tracks stable are switched to a destabilizing mode.
Microtubule destabilizing proteins SCG10 and stathmin regulate neuronal growth and contribute to the cytoskeletal dynamics that underlie growth cone behavior. Their activity influences whether the neurite can extend or must retract, placing them among the effectors that execute negative regulation of neuron projection regeneration. This microtubule-level control complements actin-based collapse mechanisms.
Receptor-level inhibition by Celsr2 and related guidance molecules
In simple terms: A receptor on the neuron surface acts as a brake on axon growth and bundling.
Inactivating Celsr2 promotes motor axon fasciculation and regeneration in mouse and human, indicating that Celsr2 normally contributes to negative regulation of neuron projection regeneration. This demonstrates that a single guidance receptor can gate regenerative capacity across species. Such receptor-level control provides a genetically tractable entry point for manipulating GO:0070571.
Post-transcriptional suppression of regeneration-associated proteins
In simple terms: Small RNA molecules reduce the amount of proteins needed for nerve regrowth.
MiR-463-3p inhibits tibial nerve regeneration via post-transcriptional suppression of SPRR1A, showing that microRNA-mediated repression of regeneration-associated proteins is a mechanism of negative regulation. This layer of control acts after transcription and can rapidly tune the regenerative response. It illustrates that GO:0070571 is not limited to receptor-proximal signaling but includes downstream gene-expression control.
Integration with injury-induced gene expression programs
In simple terms: After injury, many genes change their activity, and some of those changes keep the axon from regrowing.
Gene expression changes after focal stroke, traumatic brain and spinal cord injuries reshape the molecular environment that determines regenerative success. These injury-induced programs include both growth-promoting and growth-inhibitory components, and the inhibitory components fall within GO:0070571. Understanding this integration helps explain why regeneration fails in the injured CNS despite the presence of growth-capable neurons.
Key Genes Involved in GO:0070571 negative regulation of neuron projection regeneration
The following genes and proteins have been experimentally linked to negative regulation of neuron projection regeneration or to the growth cone collapse processes that define it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RhoA | Rho-family GTPase that promotes growth cone collapse and restrains neurite extension | Dominant negative RhoA enhances sciatic nerve regeneration in vivo |
| Rac1 | Rho-family GTPase involved in cytoskeletal reorganization and growth cone dynamics | Dominant negative Rac1 enhances sciatic nerve regeneration |
| Celsr2 | Atypical cadherin guidance receptor that limits motor axon fasciculation and regeneration | Inactivation promotes regeneration in mouse and human |
| SCG10 | Microtubule destabilizing protein regulating neuronal growth | Effector of cytoskeletal dynamics in growth cones |
| STMN1 (stathmin) | Microtubule destabilizing protein regulating neuronal growth | Modulates neurite extension and retraction |
| SPRR1A | Regeneration-associated protein suppressed post-transcriptionally | Target of miR-463-3p in tibial nerve regeneration |
| MIR463 (miR-463-3p) | MicroRNA that inhibits tibial nerve regeneration | Suppresses SPRR1A to restrain regeneration |
| PIEZO1 | Mechanosensitive ion channel modulating neurite outgrowth | Magnetically guided neurite outgrowth in hiPSC-derived retinal ganglion cells |
| NCAM1 | Cell adhesion molecule regulating neurite outgrowth | Model for adhesion-dependent growth control |
| L1CAM | Cell adhesion molecule regulating neurite outgrowth | Model for adhesion-dependent growth control |
| CDH2 (N-cadherin) | Cell adhesion molecule implicated in neurite outgrowth regulation | Adhesion-based regulation of projection growth |
| ITGB1 (integrin beta 1) | Adhesion receptor contributing to neurite outgrowth signaling | Extracellular matrix-dependent growth regulation |
| ROCK1 | Downstream RhoA effector in cytoskeletal contraction | Candidate effector of growth cone collapse |
| LIMK1 | Actin cytoskeleton regulator downstream of Rho GTPases | Candidate effector of neurite retraction |
| CFL1 (cofilin) | Actin depolymerizing factor linked to growth cone dynamics | Effector of cytoskeletal collapse |
| MAPT (tau) | Microtubule-associated protein influencing neurite stability | Context for microtubule destabilization studies |
| GAP43 | Growth-associated protein linked to neurite outgrowth | Contrast marker for growth-promoting states |
How Is negative regulation of neuron projection regeneration Regulated?
Negative regulation of neuron projection regeneration is controlled at multiple levels. Rho-family GTPase signaling acts as a central switch, since dominant negative RhoA and Rac1 enhance sciatic nerve regeneration, showing that these GTPases restrain regrowth. Receptor-level control is exemplified by Celsr2, whose inactivation promotes motor axon fasciculation and regeneration in mouse and human. Microtubule destabilizing proteins SCG10 and stathmin regulate neuronal growth and provide a cytoskeletal regulatory layer. Post-transcriptional control by miR-463-3p suppresses SPRR1A and inhibits tibial nerve regeneration, adding an RNA-level brake. Finally, injury-induced gene expression changes after stroke, traumatic brain injury and spinal cord injury reshape the balance of growth-promoting and growth-inhibitory cues, and cell adhesion molecules provide environmental regulation of neurite outgrowth.
negative regulation of neuron projection regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RhoA | Peripheral nerve regeneration failure | Dominant negative RhoA adenovirus in sciatic nerve injury models |
| Rac1 | Peripheral nerve regeneration failure | Dominant negative Rac1 adenovirus in sciatic nerve injury models |
| Celsr2 | Motor axon fasciculation and regeneration defects | Celsr2 inactivation in mouse and human motor axon systems |
| SPRR1A / miR-463-3p | Tibial nerve regeneration inhibition | MicroRNA suppression and target rescue in nerve injury models |
| PIEZO1 | Retinal ganglion cell neurite outgrowth | hiPSC-derived retinal ganglion cells with magnetic guidance |
Failed CNS regeneration after stroke and trauma
Gene expression changes after focal stroke, traumatic brain and spinal cord injuries alter the molecular programs that govern regeneration, and inhibitory components of these programs correspond to GO:0070571. Because negative regulation actively restrains regrowth, it is a candidate target for therapies aimed at improving recovery after CNS injury. Experimental manipulation of inhibitory cues has been proposed as a neuroregenerative strategy.
Peripheral nerve regeneration defects
In the peripheral nervous system, miR-463-3p inhibits tibial nerve regeneration by suppressing SPRR1A, directly linking negative regulation of neuron projection regeneration to impaired nerve repair. Conversely, dominant negative RhoA and Rac1 enhance sciatic nerve regeneration, showing that relieving inhibition can improve outcomes. These findings support the view that peripheral nerve regeneration is limited by active inhibitory signaling.
Motor axon fasciculation and regeneration disorders
Celsr2 inactivation promotes motor axon fasciculation and regeneration in both mouse and human systems, implicating this receptor in the negative regulation of motor axon regrowth. Dysregulation of such guidance receptors could contribute to regeneration failure in motor neuron injury or disease contexts. This provides a cross-species rationale for targeting Celsr2-related pathways.
Retinal ganglion cell neurite outgrowth and mechanotransduction
Magnetically guided neurite outgrowth modulated by PIEZO1 in hiPSC-derived retinal ganglion cells shows that mechanosensitive channels influence projection growth in human neurons. This connects physical cues to the regulation of neurite extension and provides a human cell model for studying inhibitory and promoting signals. It broadens the disease relevance of GO:0070571 to optic nerve and retinal repair research.
From negative regulation of neuron projection regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene relieve negative regulation of axon regrowth? | CRISPR knockout in primary neurons or neuronal cell lines |
| Does a specific point mutation alter growth cone collapse signaling? | CRISPR point-mutation knock-in in neuronal cells |
| Can a regeneration-associated protein be restored to promote regrowth? | Knock-in or tagged knock-in of the target gene |
| Does overexpression of an inhibitory GTPase block neurite extension? | Overexpression of RhoA or Rac1 constructs in neurons |
| Does receptor inactivation promote regeneration in vivo? | Celsr2 inactivation in mouse and human motor axon models |
| Does mechanosensitive channel activity modulate neurite outgrowth? | PIEZO1 modulation in hiPSC-derived retinal ganglion cells |
How to Study the negative regulation of neuron projection regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Neurite outgrowth assay | Length and number of neuronal processes | Testing whether a gene restrains or promotes regrowth |
| Growth cone collapse assay | Retraction of the growth cone tip | Direct readout of negative regulation of neuron projection regeneration |
| Sciatic nerve regeneration index | Functional and structural nerve repair in vivo | Evaluating dominant negative GTPase effects |
| Axon fasciculation measurement | Bundling and regeneration of motor axons | Testing Celsr2 inactivation in mouse and human |
| Transcriptomic profiling | Gene expression changes after injury | Identifying inhibitory programs after stroke or trauma |
| MicroRNA target validation | Post-transcriptional suppression of regeneration proteins | Confirming miR-463-3p regulation of SPRR1A |
| hiPSC-derived neuron outgrowth assay | Human neurite extension under physical cues | Studying PIEZO1-dependent modulation |
| Cell adhesion substrate assay | Adhesion-dependent neurite outgrowth | Modeling environmental regulation of growth |
Neurite outgrowth and growth cone collapse assays
Neurite outgrowth assays quantify the length and number of neuronal processes, while growth cone collapse assays measure retraction of the motile tip, the classical readout for GO:0070571. These assays can be combined with dominant negative GTPase expression to test whether a candidate gene restrains regeneration. Cell adhesion molecule substrates are often used to model environmental regulation of outgrowth.
Genetic manipulation and regeneration indices in vivo
Adenovirus-mediated expression of dominant negative RhoA and Rac1 enhances sciatic nerve regeneration, providing an in vivo paradigm for testing negative regulators. Celsr2 inactivation promotes motor axon fasciculation and regeneration in mouse and human, illustrating cross-species validation. Nerve regeneration indices and axon fasciculation measurements are typical endpoints.
Transcriptomic and post-transcriptional analysis
Gene expression changes after focal stroke, traumatic brain and spinal cord injuries can be profiled to identify inhibitory programs within GO:0070571. MicroRNA-mediated suppression of SPRR1A by miR-463-3p demonstrates the value of post-transcriptional analysis in nerve regeneration research. Combining transcriptomics with target validation helps distinguish correlation from causation.
Human cell models and mechanotransduction studies
hiPSC-derived retinal ganglion cells provide a human neuronal platform for studying neurite outgrowth and its modulation by PIEZO1 under magnetic guidance. Such models allow human-relevant testing of genes implicated in negative regulation of neuron projection regeneration. They complement rodent injury models and primary neuron assays.
How CRISPR Can Be Used to Study GO:0070571 negative regulation of neuron projection regeneration
Knockout
CRISPR knockout of candidate inhibitory genes such as RhoA, Rac1, or Celsr2 can test whether removing the gene relieves negative regulation of neuron projection regeneration. Knockout in primary neurons or neuronal cell lines followed by neurite outgrowth assays provides a direct functional readout. In vivo knockout or inactivation can be combined with nerve injury models to assess regeneration indices.
Point Mutation
Point-mutation knock-in can dissect specific residues required for growth cone collapse signaling, for example in GTPase switch regions or cytoskeletal effector domains. Such models help distinguish catalytic or binding functions from scaffolding roles. They are particularly useful when complete knockout causes developmental lethality or confounding phenotypes.
Knock-in
Knock-in of tagged or reporter alleles allows visualization and purification of proteins involved in negative regulation of neuron projection regeneration. Knock-in of regeneration-associated proteins such as SPRR1A can test whether restoring expression overcomes microRNA-mediated inhibition. Tagged knock-in also enables proteomic and imaging studies of growth cone components.
Overexpression
Overexpression of RhoA, Rac1, or other inhibitory factors can force growth cone collapse and block neurite extension, providing gain-of-function evidence for GO:0070571. Overexpression of PIEZO1 or its modifiers can probe mechanotransduction effects on neurite outgrowth in human neurons. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports negative regulation of neuron projection regeneration Research
Researchers studying negative regulation of neuron projection regeneration-related genes often need to determine whether a candidate gene is causally involved in restraining axon or dendrite regrowth, and CRISPR-based models provide the most direct way to test that causality.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of neuron projection regeneration research.
Frequently Asked Questions About negative regulation of neuron projection regeneration
What is GO:0070571 negative regulation of neuron projection regeneration?
GO:0070571 is a Gene Ontology biological_process term describing any process that stops, prevents, or reduces the frequency, rate or extent of neuron projection regeneration, the regrowth of axons or dendrites after loss or damage.
What is the synonym for GO:0070571?
The classical synonym is growth cone collapse, reflecting the retraction of the motile growth cone tip that halts neurite extension.
What genes are involved in negative regulation of neuron projection regeneration?
Key genes include RhoA, Rac1, Celsr2, SCG10, stathmin, SPRR1A, miR-463-3p, PIEZO1, and several cell adhesion molecules such as NCAM1 and L1CAM.
How does RhoA signaling inhibit axon regeneration?
RhoA activation reorganizes the actin cytoskeleton and drives growth cone collapse, and dominant negative RhoA enhances sciatic nerve regeneration in vivo.
What is the role of Celsr2 in axon regeneration?
Inactivating Celsr2 promotes motor axon fasciculation and regeneration in mouse and human, indicating that Celsr2 normally restrains regeneration.
How do microRNAs regulate neuron projection regeneration?
MiR-463-3p inhibits tibial nerve regeneration by post-transcriptionally suppressing SPRR1A, providing an RNA-level brake on regrowth.
Which diseases are linked to failed neuron projection regeneration?
Failed regeneration is linked to stroke, traumatic brain injury, spinal cord injury, peripheral nerve injury, and motor axon regeneration disorders.
What assays measure negative regulation of neuron projection regeneration?
Neurite outgrowth assays, growth cone collapse assays, nerve regeneration indices, axon fasciculation measurements, and transcriptomic profiling are commonly used.
Can CRISPR be used to study negative regulation of neuron projection regeneration?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate inhibitory genes in neurons and animal models.
What is the difference between growth cone collapse and neuron projection regeneration?
Growth cone collapse is the retraction of the growing tip and is a synonym for the inhibitory process, whereas neuron projection regeneration is the regrowth of axons or dendrites after damage.
Conclusion
GO:0070571, negative regulation of neuron projection regeneration, defines the active cellular programs that restrain axon and dendrite regrowth after injury, including growth cone collapse and its underlying signaling and cytoskeletal events. Its key regulators, such as RhoA, Rac1, Celsr2, SCG10/stathmin, SPRR1A, and miR-463-3p, provide experimentally tractable entry points for neuroregeneration research. Because injury-induced gene expression changes after stroke, traumatic brain injury and spinal cord injury reshape these inhibitory programs, the term is directly relevant to translational efforts to improve neural repair. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, together with library screening and bioinformatics, offer a rigorous path to establish causality and identify new therapeutic targets within this process.
References
- 1. Kusano K et al.. 2011. Enhancement of sciatic nerve regeneration by adenovirus-mediated expression of dominant negative RhoA and Rac1.. Neurosci Lett 492(1):64-9 PMID: 21281699
- 2. Chen IT et al.. 2025. Magnetically guided neurite outgrowth modulated by PIEZO1 in hiPSC-derived retinal ganglion cells.. Mater Today Bio 35:102446 PMID: 41209706
- 3. Wen Q et al.. 2022. Inactivating Celsr2 promotes motor axon fasciculation and regeneration in mouse and human.. Brain 145(2):670-683 PMID: 34983065
- 4. Kiryushko D et al.. 2004. Regulators of neurite outgrowth: role of cell adhesion molecules.. Ann N Y Acad Sci 1014:140-54 PMID: 15153429
- 5. Carmichael ST. 2003. Gene expression changes after focal stroke, traumatic brain and spinal cord injuries.. Curr Opin Neurol 16(6):699-704 PMID: 14624079
- 6. Zhao J et al.. 2019. MiR-463-3p inhibits tibial nerve regeneration via post-transcriptional suppression of SPRR1A.. Artif Cells Nanomed Biotechnol 47(1):3631-3637 PMID: 31468997
- 7. Grenningloh G et al.. 2004. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth.. J Neurobiol 58(1):60-9 PMID: 14598370
- 8. Skaper SD. 2012. Neuronal growth-promoting and inhibitory cues in neuroprotection and neuroregeneration.. Methods Mol Biol 846:13-22 PMID: 22367797
